SurModics (SRDX) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to SurModics (SRDX) Tops Q2 EPS by 11c
May 2, 2016 4:50 PM EDT
GAAP Revenue of $16.7 Million, up 16%, Third Consecutive Quarter of
Double-Digit Growth
GAAP EPS of $0.06, Non-GAAP EPS of $0.20
SurVeil Drug-Coated Balloon Commences IDE
Study
Raises Revenue and Non-GAAP EPS Guidance Ranges
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, today
announced results for its fiscal 2016 second quarter, ended March 31,
2016.
For the third consecutive quarter, we... More
April 28, 2016 7:05 PM EDT
Webcast is Live at 4 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--
SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and
in vitro diagnostic technologies to the healthcare industry, today
announced that it will host a live webcast of its second quarter fiscal
2016 conference call on Monday, May 2, at 4 p.m. CT (5 p.m. ET). The
Company will issue an earnings news release after the market closes that
afternoon.
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance... More
